
Evoral Plus 0.05mg/0.25mg Tablet
Marketer
Wellencia Lifesciences
Salt Composition
Ethinyl Estradiol (0.05mg) + Levonorgestrel (0.25mg)
Overview Evoral Plus 0.05mg/0.25mg Tablet
Combifem 0.05mg/0.25mg tablets are indicated for birth control and managing menstrual irregularities. This medication prevents ovulation and fertilization. Combifem 0.05mg/0.25mg tablets may be taken with or without food, but consistent daily timing is crucial for optimal efficacy. Always follow your physician's instructions; initiate daily use on the first day of your menstrual cycle and continue for a full month, beginning a new pack immediately after finishing the previous one. If vomiting occurs within four hours of ingestion, take a replacement tablet. If a dose is missed by up to 12 hours, utilize barrier contraception (e.g., condoms) for two days. Common side effects include nausea, headache, and breast tenderness. Report persistent or severe side effects to your doctor; management strategies may be available. Intermenstrual bleeding or amenorrhea may occur; consult your doctor if this is frequent or prolonged. Seek immediate medical attention if you experience limb swelling and pain, dyspnea, chest pain, or visual disturbances, as these may signal a blood clot. Before commencing treatment, disclose smoking status (particularly if over 35), history of heart attack, uterine/cervical/vaginal cancer, and all other medications you are currently using, as interactions may affect the drug's efficacy. Do not use if pregnant or breastfeeding.
Uses of Evoral Plus 0.05mg/0.25mg Tablet
Birth control
Major Benefits of Evoral Plus 0.05mg/0.25mg Tablet:
Administer Evoral Plus 0.05mg/0.25mg tablets according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consumption with or without food is acceptable, although consistent timing is recommended.
Common Side effects of Evoral Plus 0.05mg/0.25mg Tablet:
- Nausea
- Headache
- Breast pain
- Abdominal pain
- Weight gain
- Depression
How to use Evoral Plus 0.05mg/0.25mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Evoral Plus 0.05mg/0.25mg tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
How Evoral Plus 0.05mg/0.25mg Tablet works:
FemmeGuard 0.05mg/0.25mg tablets function as a combined oral contraceptive, inhibiting ovulation and impairing sperm motility within the uterus to hinder fertilization. Additionally, it modifies the uterine lining, making it inhospitable to implantation.
SAFETY ADVICE
AlcoholCAUTION
Use of Evoral Plus 0.05mg/0.25mg Tablets with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyUNSAFE
The use of Evoral Plus 0.05mg/0.25mg tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician, as research in both animal and human subjects has revealed substantial adverse effects on fetal development.
Breast feedingCONSULT YOUR DOCTOR
The use of Evoral Plus 0.05mg/0.25mg tablets while breastfeeding is likely inadvisable. Available evidence from humans indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability may be unaffected by Evoral Plus 0.05mg/0.25mg Tablet, but refrain from driving if concentration or reaction time is impaired.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Evoral Plus 0.05mg/0.25mg Tablet use in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Evoral Plus 0.05mg/0.25mg Tablet in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Evoral Plus 0.05mg/0.25mg Tablet :
Omitting a dose of Evoral Plus 0.05mg/0.25mg Tablet necessitates contacting your physician.
Facts to Know About Evoral Plus 0.05mg/0.25mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Obstetrics and Gynecology |
